Tag: Hatch-Waxman Act
-
Why Brand Companies Launch Authorized Generics: The Real Strategy Behind the Move
Brand companies launch authorized generics not to give away profits, but to control the market after patent expiry. These identical drugs let them keep revenue, block competitors, and keep patients loyal - all while lowering prices.